Elaine M Weidenhammer

Title: Innovations by Elaine M Weidenhammer

Introduction

Elaine M Weidenhammer is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of gene expression monitoring through her innovative techniques and methods. With a total of 2 patents, her work has advanced the understanding of nucleic acid hybridization assays.

Latest Patents

Her latest patents include "Quantitative analysis methods on active electronic microarrays" and "Methods for gene expression monitoring on electronic microarrays." The first patent presents techniques useful in methods for gene expression monitoring, utilizing microelectronic arrays to drive the transport and hybridization of nucleic acids. It provides methods for normalizing the signals of individual microlocations using an internal control sequence probe. This is particularly beneficial for hybridization assays that require quantitative comparisons of different sequences across multiple microlocations. The second patent outlines methods for generating mRNA expression samples from various biological materials, which may differ in their physiological or pathological states. It describes procedures for creating a reusable nucleic acid transcript library and improving gene expression monitoring on microelectronic arrays.

Career Highlights

Elaine is currently associated with Nanogen, Inc., where she continues to innovate in the field of biotechnology. Her work has been instrumental in developing methods that correlate changes in mRNA levels with the expression of encoded proteins, aiding in the study of gene expression in diseases.

Collaborations

Throughout her career, Elaine has collaborated with notable coworkers, including Ling Wang and Xiao Xu. Their combined efforts have contributed to the advancement of research in gene expression monitoring.

Conclusion

Elaine M Weidenhammer's contributions to the field of biotechnology through her patents and innovative methods have significantly impacted gene expression monitoring. Her work continues to pave the way for advancements in understanding genetic information and its implications in health and disease.